01 6NEUROCRINE
01 610906903
01 6Y
01 6Y
01 62036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218390
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218390
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2036-12-22
US Patent Number : 10906903
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218390
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
